Maria do Carmo Araújo
Universidade Federal de Santa Maria
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maria do Carmo Araújo.
Clinical Biochemistry | 2008
Vanessa Battisti; Liési D.K. Maders; Margarete Dulce Bagatini; Karen F. Santos; Roselia Spanevello; Paula Acosta Maldonado; Alice Odete Brülê; Maria do Carmo Araújo; Maria Rosa Chitolina Schetinger; Vera Maria Morsch
OBJECTIVES To evaluate the oxidative status and antioxidant defense in patients with acute lymphoblastic leukemia (ALL). DESIGN AND METHODS We measured concentrations of plasmatic thiobarbituric acid reactive substances (TBARS), serum protein carbonylation, whole blood catalase (CAT) and superoxide dismutase (SOD) activities, as well as the plasmatic and erythrocyte thiol levels and serum vitamin E concentration. This study was performed on 80 children with ALL divided into 4 groups: just diagnosed, remission induction, remission maintenance and out-of-treatment. RESULTS TBARS levels and serum protein carbonylation were higher in ALL patients than in controls and reduced levels of antioxidants were found in these patients. CONCLUSION These findings may indicate a possible link between decreased antioxidants and increased levels of cells alterations due to oxidative damage, supporting the idea that there is a persistence of oxidative stress in acute lymphoblastic leukemia.
Evidence-based Complementary and Alternative Medicine | 2012
Maria do Carmo Araújo; Iria Luiza Gomes Farias; Jessié M. Gutierres; Sérgio Luiz Dalmora; Nélia Flores; Júlia Gomes Farias; Ivana de Cruz; Juarez Chiesa; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Breast cancer is the most frequent neoplasm affecting women worldwide. Some of the recommended treatments involve chemotherapy whose toxic effects include leukopenia and neutropenia. This study assessed the effectiveness of Uncaria tomentosa (Ut) in reducing the adverse effects of chemotherapy through a randomized clinical trial. Patients with Invasive Ductal Carcinoma—Stage II, who underwent a treatment regimen known as FAC (Fluorouracil, Doxorubicin, Cyclophosphamide), were divided into two groups: the UtCa received chemotherapy plus 300 mg dry Ut extract per day and the Ca group that only received chemotherapy and served as the control experiment. Blood samples were collected before each one of the six chemotherapy cycles and blood counts, immunological parameters, antioxidant enzymes, and oxidative stress were analyzed. Uncaria tomentosa reduced the neutropenia caused by chemotherapy and was also able to restore cellular DNA damage. We concluded that Ut is an effective adjuvant treatment for breast cancer.
Clinica Chimica Acta | 2009
Vanessa Battisti; Maria Rosa Chitolina Schetinger; Liési D.K. Maders; Karen F. Santos; Margarete Dulce Bagatini; Maísa de Carvalho Corrêa; Roselia Spanevello; Maria do Carmo Araújo; Vera Maria Morsch
BACKGROUND Acute lymphoblastic leukemia (ALL) is a type of cancer that affects lymphocytes and it is the most common form of cancer in children. Acetylcholinesterase (AChE) is well known as having non-cholinergic functions and has been detected in the blood and plasma of humans including in lymphocytes. Thus, we investigated whole blood and lymphocyte AChE activity in patients with ALL. METHODS This study was performed on 72 children with ALL divided into 4 groups: newly diagnosed, remission induction, remission maintenance and out-of-treatment and one control group of 50 healthy subjects. We determined AChE activity in whole blood and lymphocytes of these patients. RESULTS Results demonstrated that whole blood AChE activity was enhanced in the newly diagnosed group and reduced in the remission induction and remission maintenance groups in relation to the control group. For lymphocyte AChE activity we found an increase in the newly diagnosed group and a decrease in the remission induction group in relation to the control. CONCLUSIONS These results suggest that AChE activity was altered in ALL patients. This fact may be related with the essential role played by AChE in the development of hematological disease and its contribution to the regulation of immune function.
Biomedicine & Pharmacotherapy | 2014
Daniela Zanini; Luana Paula Pelinson; Roberta Schmatz; Luciane Belmonte Pereira; Caroline Curry Martins; Jucimara Baldissareli; Guilherme Pires Amaral; Félix Alexandre Antunes Soares; Luiz Gustavo Brenner Reetz; Maria do Carmo Araújo; Juarez Chiesa; Vera Maria Morsch; Daniela Bitencourt Rosa Leal; Maria Rosa Chitolina Schetinger
This study investigated the δ-aminolevulinate dehydratase (δ-ALA-D) activity in whole blood as well as the parameters of oxidative stress, such as reactive species (RS) levels in serum, thiobarbituric acid reactive substances (TBARS) levels, the superoxide dismutase (SOD) and catalase (CAT) activities, as well as total thiols (T-SH) and non-protein thiols (NPSH) levels in platelets. Moreover, the content of vitamin C and E in plasma and serum, respectively, in lung cancer patients was also investigated. We collected blood samples from patients (n=28) previously treated for lung cancer with chemotherapy. Patients were classified as stage IIIb and IV according to the Union for International Cancer Control (UICC). Results showed a decrease of 37% in δ-ALA-D activity in patients with lung cancer when compared to the control group. RS and TBARS levels were 8% and 99% higher in the patient group, respectively. The activity of SOD and CAT as well as the vitamin C content were 41%, 35% and 127% lower in patients when compared with controls, respectively. However, T-SH and vitamin E levels were 27% and 44% higher in lung cancer patients, respectively. Results show that the overproduction of reactive species in patients with lung cancer may be interfering with the activity of δ-ALA-D. Likewise, the decrease in the activity of this enzyme may be contributing for the oxidative stress.
Environmental Toxicology | 2016
Camila Murussi; Charlene Menezes; Mauro E. Nunes; Maria do Carmo Araújo; Vanessa A. Quadros; Denis Broock Rosemberg; Vania Lucia Loro
Azadirachtin (Aza) is a promisor biopesticide used in organic production and aquaculture. Although this compound is apparently safe, there is evidence that it may have deleterious effects on fish. Behavioral and hematological tests are grouped into a set of parameters that may predict potential toxicity of chemical compounds. Here, we investigate the effects of Aza, in the commercial formulation Neenmax™, on carp (Cyprinus carpio) by defining LC50 (96 h), and testing behavioral and hematological parameters. In our study, LC50 was estimated at 80 μL/L. We exposed carp to Aza at 20, 40, and 60 μL/L, values based on 25, 50, and 75% of LC50, respectively. At 60 μL/L, Aza promoted significant changes in several parameters, increasing the distance traveled and absolute turn angle. In addition, the same concentration decreased the time spent immobile and the number of immobile episodes. Hematological parameters, such as hematocrit, hemoglobin, hematimetrics index, and red cell distribution, were decreased at 60 μL/L Aza exposure. In conclusion, our study demonstrates that 60 μL/L Aza altered locomotor activity, motor pattern, and hematological parameters, suggesting potential toxicity to carp after acute exposure. In addition, this is the first report that evaluates the actions of a chemical contaminant using automated behavioral tracking of carp, which may be a useful tool for assessing the potential toxicity of biopesticides in conjunction with hematological tests.
Biochimica et Biophysica Acta | 2005
Maria do Carmo Araújo; João Batista Teixeira da Rocha; André Morsch; Rafael Fernandes Zanin; Rita Bauchspiess; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Molecular and Cellular Biochemistry | 2013
Daniela Zanini; Roberta Schmatz; Luana Paula Pelinson; Victor Camera Pimentel; Pauline da Costa; Andréia Machado Cardoso; Caroline Curry Martins; Christina Chitolina Schetinger; Jucimara Baldissareli; Maria do Carmo Araújo; Liliane Oliveira; Juarez Chiesa; Vera Maria Morsch; Daniela Bitencourt Rosa Leal; Maria Rosa Chitolina Schetinger
Diabetes Research and Clinical Practice | 2008
Gilberto Lunkes; Daniéle Sausen Lunkes; Daniela Bitencourt Rosa Leal; Maria do Carmo Araújo; Maísa Corrêa; Lara Vargas Becker; Cíntia Saydelles da Rosa; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Clinica Chimica Acta | 2006
Paula Acosta Maldonado; Luiz Augusto Negrini; Rosilene Rodrigues Kaizer; Rafael Fernandes Zanin; Maria do Carmo Araújo; Vanessa Battisti; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Biochimica et Biophysica Acta | 2005
Adriane Cismoski da Silva; André Morsch; Rafael Fernandes Zanin; Maísa de Carvalho Corrêa; Luís C. Arantes; Maria do Carmo Araújo; Vera Maria Morsch; Maria Rosa Chitolina Schetinger